Interpretation of variants of uncertain clinical significance (vucs): The paradigm of usher syndrome

Inner Ear Development and Hearing Loss

Volumn , Issue , 2013, Pages 159-173

  Baux, D ^a   Vache C ^a   Malcolm, S ^b   Claustres, M ^a,c,d   Roux, A F ^a,c  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c INSERM   (France)

^d UNIV MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892804929     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (43)

1. Kimberling WJ, Hildebrand MS, Shearer AE, Jensen ML, Halder JA, Trzupek K, Cohn ES, Weleber RG, Stone EM, Smith RJ: Frequency of Usher syndrome in two pediatric populations: Implications for genetic screening of deaf and hard of hearing children. Genet Med 2010, 12(8):512-516.
2. Saihan Z, Webster AR, Luxon L, Bitner-Glindzicz M: Update on Usher syndrome. Curr Opin Neurol 2009, 22(1):19-27.
3. Ebermann I, Phillips JB, Liebau MC, Koenekoop RK, Schermer B, Lopez I, Schafer E, Roux AF, Dafinger C, Bernd A et al: PDZD7 is a modifier of retinal disease and a contributor to digenic Usher syndrome. J Clin Invest 2010, 120(6):1812-1823.
4. Le Quesne Stabej P, Saihan Z, Rangesh N, Steele-Stallard HB, Ambrose J, Coffey A, Emmerson J, Haralambous E, Hughes Y, Steel KP et al: Comprehensive sequence analysis of nine Usher syndrome genes in the UK National Collaborative Usher Study. Journal of medical genetics 2012, 49(1):27-36.
5. Astuto LM, Bork JM, Weston MD, Askew JW, Fields RR, Orten DJ, Ohliger SJ, Riazuddin S, Morell RJ, Khan S et al: CDH23 mutation and phenotype heterogeneity: a profile of 107 diverse families with Usher syndrome and nonsyndromic deafness. Am J Hum Genet 2002, 71(2):262-275.
6. Garcia-Garcia G, Aparisi MJ, Jaijo T, Rodrigo R, Leon AM, Avila-Fernandez A, Blanco-Kelly F, Bernal S, Navarro R, Diaz-Llopis M et al: Mutational screening of the USH2A gene in Spanish USH patients reveals 23 novel pathogenic mutations. Orphanet J Rare Dis 2011, 6:65.
7. Kalay E, de Brouwer AP, Caylan R, Nabuurs SB, Wollnik B, Karaguzel A, Heister JG, Erdol H, Cremers FP, Cremers CW et al: A novel D458V mutation in the SANS PDZ binding motif causes atypical Usher syndrome. J Mol Med 2005, 83(12):1025-1032.
8. Bashir R, Fatima A, Naz S: A frameshift mutation in SANS results in atypical Usher syndrome. Clinical genetics 2010, 78(6):601-603.
9. Abadie C, Blanchet C, Baux D, Larrieu L, Besnard T, Ravel P, Biboulet R, Hamel C, Malcolm S, Mondain M et al: Audiological findings in 100 USH2 patients. Clinical genetics 2011.
10. Dreyer B, Tranebjaerg L, Brox V, Rosenberg T, Moller C, Beneyto M, Weston MD, Kimberling WJ, Cremers CW, Liu XZ et al: A common ancestral origin of the frequent and widespread 2299delG USH2A mutation. Am J Hum Genet 2001, 69(1):228-234.
11. Aller E, Larrieu L, Jaijo T, Baux D, Espinos C, Gonzalez-Candelas F, Najera C, Palau F, Claustres M, Roux AF et al: The USH2A c.2299delG mutation: dating its common origin in a Southern European population. Eur J Hum Genet 2010, 18(7):788-793.
12. Roux AF, Faugere V, Vache C, Baux D, Besnard T, Leonard S, Blanchet C, Hamel C, Mondain M, Gilbert-Dussardier B et al: Four year follow-up of diagnostic service in USH1 patients. Invest Ophthalmol Vis Sci 2011, 52(7):4063-4071.
13. Dreyer B, Brox V, Tranebjaerg L, Rosenberg T, Sadeghi AM, Moller C, Nilssen O: Spectrum of USH2A mutations in Scandinavian patients with Usher syndrome type II. Hum Mutat 2008, 29(3):451.
14. Besnard T, Vache C, Baux D, Larrieu L, Abadie C, Blanchet C, Odent S, Blanchet P, Calvas P, Hamel C et al: Non-USH2A Mutations in USH2 Patients. Human mutation 2012, 33(3):504-510.
15. Zheng QY, Yan D, Ouyang XM, Du LL, Yu H, Chang B, Johnson KR, Liu XZ: Digenic inheritance of deafness caused by mutations in the genes encoding cadherin 23 and protocadherin 15 in mice and humans. Hum Mol Genet 2005, 14:103-111.
16. Bonnet C, Grati M, Marlin S, Levilliers J, Hardelin JP, Parodi M, Niasme-Grare M, Zelenika D, Delepine M, Feldmann D et al: Complete exon sequencing of all known Usher syndrome genes greatly improves molecular diagnosis. Orphanet J Rare Dis 2011, 6(1):21.
17. Vaché C, Besnard T, le Berre P, Garcia-Garcia G, Baux D, Larrieu L, Abadie C, Blanchet C, Bolz HJ, Millan J et al: Usher syndrome type 2 caused by activation of an USH2A pseudoexon: Implications for diagnosis and therapy. Human mutation 2012, 33(1):104-108.
18. Adato A, Kalinski H, Weil D, Chaib H, Korostishevsky M, Bonne-Tamir B: Possible interaction between USH1B and USH3 gene products as implied by apparent digenic deafness inheritance [letter]. Am J Hum Genet 1999, 65(1):261-265.
19. Vaché C, Besnard T, Blanchet C, Baux D, Larrieu L, Faugère V, Mondain M, Hamel C, Malcolm S, Claustres M et al: Nasal epithelial cells are a reliable source to study splicing variants in Usher syndrome. Hum Mutat 2010, 31(6):734-741.
20. Flanigan KM, Dunn DM, von Niederhausern A, Soltanzadeh P, Howard MT, Sampson JB, Swoboda KJ, Bromberg MB, Mendell JR, Taylor LE et al: Nonsense mutation-associated Becker muscular dystrophy: interplay between exon definition and splicing regulatory elements within the DMD gene. Human mutation 2011, 32(3):299-308.
21. Mazoyer S, Dunning AM, Serova O, Dearden J, Puget N, Healey CS, Gayther SA, Mangion J, Stratton MR, Lynch HT et al: A polymorphic stop codon in BRCA2. Nature genetics 1996, 14(3):253-254.
22. Sandelin A, Wasserman WW, Lenhard B: ConSite: web-based prediction of regulatory elements using cross-species comparison. Nucleic acids research 2004, 32(Web Server issue):W249-252.
23. Schug J: Using TESS to predict transcription factor binding sites in DNA sequence. Curr Protoc Bioinformatics 2008, Chapter 2:Unit 2 6.
24. Lewis BP, Burge CB, Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120(1):15 20.
25. Lopez E, Viart V, Guittard C, Templin C, Rene C, Mechin D, Des Georges M, Claustres M, Romey-Chatelain MC, Taulan M: Variants in CFTR untranslated regions are associated with congenital bilateral absence of the vas deferens. Journal of Medical Genetics 2011, 48(3):152-159.
26. von Brederlow B, Bolz H, Janecke A, La OCA, Rudolph G, Lorenz B, Schwinger E, Gal A: Identification and in vitro expression of novel CDH23 mutations of patients with Usher syndrome type 1D. Hum Mutat 2002, 19(3):268-273.
27. Le Guédard-Mereuze S, Vaché C, Baux D, Faugère V, Larrieu L, Abadie C, Janecke A, Claustres M, Roux AF, Tuffery-Giraud S: Ex vivo splicing assays of mutations at non-canonical positions of splice sites in USHER genes. Hum Mutat 2010, 31:347-355.
28. Nakanishi H, Ohtsubo M, Iwasaki S, Hotta Y, Mizuta K, Mineta H, Minoshima S: Hair roots as an mRNA source for mutation analysis of Usher syndrome-causing genes. J Hum Genet 2010, 55(10):701-703.
29. Bhattacharya G, Kalluri R, Orten DJ, Kimberling WJ, Cosgrove D: A domain-specific usherin/collagen IV interaction may be required for stable integration into the basement membrane superstructure. Journal of cell science 2004, 117(Pt 2):233-242.
30. Dreyer B, Tranebjaerg L, Rosenberg T, Weston MD, Kimberling WJ, Nilssen O: Identification of novel USH2A mutations: implications for the structure of USH2A protein. Eur J Hum Genet 2000, 8(7):500-506.
31. Najera C, Beneyto M, Blanca J, Aller E, Fontcuberta A, Millan JM, Ayuso C: Mutations in myosin VIIA (MYO7A) and usherin (USH2A) in Spanish patients with Usher syndrome types I and II, respectively. Hum Mutat 2002, 20(1):76-77.
32. Kumar P, Henikoff S, Ng PC: Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 2009, 4(7):1073 1081.
33. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR: A method and server for predicting damaging missense mutations. Nat Methods 2010, 7(4):248-249.
34. Stone EA, Sidow A: Physicochemical constraint violation by missense substitutions mediates impairment of protein function and disease severity. Genome research 2005, 15(7):978-986.
35. Tavtigian SV, Deffenbaugh AM, Yin L, Judkins T, Scholl T, Samollow PB, de Silva D, Zharkikh A, Thomas A: Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral. Journal of Medical Genetics 2005, 43:295-305.
36. Tavtigian SV, Greenblatt MS, Lesueur F, Byrnes GB: In silico analysis of missense substitutions using sequence-alignment based methods. Human mutation 2008, 29(11):1327-1336.
37. Elledge HM, Kazmierczak P, Clark P, Joseph JS, Kolatkar A, Kuhn P, Muller U: Structure of the N terminus of cadherin 23 reveals a new adhesion mechanism for a subset of cadherin superfamily members. Proceedings of the National Academy of Sciences of the United States of America 2010, 107(23):10708-10712.
38. Yan J, Pan L, Chen X, Wu L, Zhang M: The structure of the harmonin/sans complex reveals an unexpected interaction mode of the two Usher syndrome proteins. Proceedings of the National Academy of Sciences of the United States of America 2010, 107(9):4040-4045.
39. Wu L, Pan L, Wei Z, Zhang M: Structure of MyTH4-FERM domains in myosin VIIa tail bound to cargo. Science 2011, 331(6018):757-760.
40. Baux D, Larrieu L, Blanchet C, Hamel C, Ben Salah S, Vielle A, Gilbert-Dussardier B, Holder M, Calvas P, Philip N et al: Molecular and in silico analyses of the full-length isoform of usherin identify new pathogenic alleles in Usher type II patients. Hum Mutat 2007, 28(8):781-789.
41. Watanabe S, Umeki N, Ikebe R, Ikebe M: Impacts of Usher syndrome type IB mutations on human myosin VIIa motor function. Biochemistry 2008, 47(36):9505 9513.
42. Villoutreix BO: Structural bioinformatics: methods, concepts and applications to blood coagulation proteins. Curr Protein Pept Sci 2002, 3(3):341-364.
43. Thusberg J, Vihinen M: Pathogenic or not? And if so, then how? Studying the effects of missense mutations using bioinformatics methods. Hum Mutat 2009, 30(5):703-714.